AstraZeneca made a commitment to deliver plain language summaries (PLS) in advance of the European Medicines Agency (EMA) policy. Partnering with Citeline, AstraZeneca decided its results would be available on TrialSummaries.com.
The hard part was the resistance from trial sites on distribution of PLS.